The new frontier in assisted reproduction: Consumer Desire vs. Regulatory and Ethical Precaution in AI-assisted Polygenic Embryo Screening
Aviad Raz, Aurélie Halsband, Robert Langner, Shiri Shkedi-Rafid
TL;DR
AI-assisted polygenic embryo screening in IVF raises ethical and regulatory questions across different national contexts.
Contribution
The paper introduces AI-assisted polygenic embryo screening and analyzes its ethical implications in three distinct national frameworks.
Findings
AI-assisted screening can predict implantation success and disease risks in embryos.
Germany, Israel, and the US show contrasting regulatory and ethical responses to the technology.
Consumer desire for the technology conflicts with legal and ethical caution in some regions.
Abstract
AI-assisted polygenic embryo screening is a new technology to predict embryonic implantation, disease risk and non-clinical traits for IVF embryos. To highlight its social and ethical implications, we locate it within the national landscapes of Germany’s legal caution, Israel’s techno-enthusiasm and US market liberalism.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsReproductive Health and Technologies · Prenatal Screening and Diagnostics · Ethics and Social Impacts of AI